Treatment modalities against the coronavirus disease 2019 (COVID-19) pandemic are limited in efficacy. This has led many centers to use
Why does convalescent plasma therapy for severe COVID-19 show mixed success?
Home ยป
Why does convalescent plasma therapy for severe COVID-19 show mixed success?
Treatment modalities against the coronavirus disease 2019 (COVID-19) pandemic are limited in efficacy. This has led many centers to use
SARS-CoV-2 variants rapidly arise in non-human hosts, potential risk for human reinfection
The coronavirus disease, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first emerged in December 2019 in Wuhan
Study addresses COVID-19 pandemic concerns and guidelines for increasing food safety
A team of researchers from the United States Department of Agriculture examined how the coronavirus disease 2019 (COVID-19) pandemic has